API Import of Palovarotene obtained from Indian Customs Trade Statistics

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 410528-02-8, Rg-667, Ro-3300074, Sohonos, Clm-001, Ipn60120
Molecular Formula
C27H30N2O2
Molecular Weight
414.5  g/mol
InChI Key
YTFHCXIPDIHOIA-DHZHZOJOSA-N
FDA UNII
28K6I5M16G

Palovarotene
Palovarotene is an orally available, selective retinoic acid receptor gamma agonist. Palovarotene selectively binds to the gamma retinoid agonist, thereby reducing inflammation and enhancing repair.
1 2D Structure

Palovarotene

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(E)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic acid
2.1.2 InChI
InChI=1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+
2.1.3 InChI Key
YTFHCXIPDIHOIA-DHZHZOJOSA-N
2.1.4 Canonical SMILES
CC1(CCC(C2=C1C=C(C(=C2)C=CC3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C
2.1.5 Isomeric SMILES
CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C
2.2 Other Identifiers
2.2.1 UNII
28K6I5M16G
2.3 Synonyms
2.3.1 MeSH Synonyms

1. R-667

2. Rg-667

3. Ro-3300074

2.3.2 Depositor-Supplied Synonyms

1. 410528-02-8

2. Rg-667

3. Ro-3300074

4. Sohonos

5. Clm-001

6. Ipn60120

7. R-667

8. R 667

9. Ipn-60120

10. Ro 3300074

11. Ro3300074

12. 4-((1e)-2-(5,5,8,8-tetramethyl-3-(1h-pyrazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl)benzoic Acid

13. 4-[(e)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic Acid

14. 28k6i5m16g

15. (e)-4-(2-(3-((1h-pyrazol-1-yl)methyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic Acid

16. Benzoic Acid, 4-((1e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(1h-pyrazol-1-ylmethyl)-2-naphthalenyl)ethenyl)-

17. Palovarotene [usan]

18. Palovarotene [usan:inn]

19. Unii-28k6i5m16g

20. Palovarotene(r 667)

21. Palovarotene (usan/inn)

22. Palovarotene [inn]

23. Palovarotene [jan]

24. Palovarotene [who-dd]

25. Gtpl8276

26. Schembl4658931

27. Chembl2105648

28. Chebi:188559

29. Dtxsid301025696

30. Bcp16664

31. Ex-a3101

32. Who 9025

33. Zb1580

34. Zinc38467831

35. Cs-2031

36. Db12320

37. Ac-36331

38. Hy-14799

39. R667

40. R 667;ro 3300074

41. D09365

42. 528p028

43. A914214

44. Q15708269

45. 4-[(e)-2-(5,5,8,8-tetramethyl-3-pyrazol-1-ylmethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)vinyl]benzoic Acid

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 414.5 g/mol
Molecular Formula C27H30N2O2
XLogP36.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count5
Exact Mass414.230728204 g/mol
Monoisotopic Mass414.230728204 g/mol
Topological Polar Surface Area55.1 Ų
Heavy Atom Count31
Formal Charge0
Complexity662
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in emphysema.


Treatment of multiple osteochondromas


Treatment of fibrodysplasia ossificans progressiva


5 Pharmacology and Biochemistry
5.1 Pharmacology

R667 is an orally active, gamma selective retinoid agonist that shows promise as a treatment for emhysema.


5.2 ATC Code

M - Musculo-skeletal system

M09 - Other drugs for disorders of the musculo-skeletal system

M09A - Other drugs for disorders of the musculo-skeletal system

M09AX - Other drugs for disorders of the musculo-skeletal system

M09AX11 - Palovarotene


5.3 Mechanism of Action

Gamma-selective retinoic acid receptor agonist.


Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty